Cargando…
Corrigendum: Randomized, Double Blind, Placebo Controlled, Clinical Trial to Study Ashwagandha Administration in Participants Vaccinated Against COVID-19 on Safety, Immunogenicity, and Protection With COVID-19 Vaccine–A Study Protocol
Autores principales: | Chopra, Arvind, Chavan-Gautam, Preeti, Tillu, Girish, Saluja, Manjit, Borse, Swapnil, Sarmukaddam, Sanjeev, Chaudhuri, Susmita, Rao, BCS, Yadav, Babita, Srikanth, Narayanam, Patwardhan, Bhushan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005450/ https://www.ncbi.nlm.nih.gov/pubmed/35433723 http://dx.doi.org/10.3389/fmed.2022.888928 |
Ejemplares similares
-
Randomized, Double Blind, Placebo Controlled, Clinical Trial to Study Ashwagandha Administration in Participants Vaccinated Against COVID-19 on Safety, Immunogenicity, and Protection With COVID-19 Vaccine–A Study Protocol
por: Chopra, Arvind, et al.
Publicado: (2022) -
Withania somnifera (L.) Dunal: Opportunity for Clinical Repurposing in COVID-19 Management
por: Saggam, Akash, et al.
Publicado: (2021) -
Co-administration of AYUSH 64 as an adjunct to standard of care in mild and moderate COVID-19: A randomized, controlled, multicentric clinical trial
por: Chopra, Arvind, et al.
Publicado: (2023) -
Evaluating higher doses of Shunthi - Guduchi formulations for safety in treatment of osteoarthritis knees: A Government of India NMITLI arthritis project
por: Chopra, Arvind, et al.
Publicado: (2012) -
Withania somnifera as a safer option to hydroxychloroquine in the chemoprophylaxis of COVID-19: Results of interim analysis
por: Chopra, Arvind, et al.
Publicado: (2021)